Skip to main content

Qbrelis News

FDA Approves Qbrelis (lisinopril) Oral Solution for Pediatric Patients 6 Years of Age and Older

Denver, July 29, 2016 — Silvergate Pharmaceuticals, Inc., leader in the development and commercialization of innovative and safe medicines for children, today announced that the United States Food a...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Myocardial Infarction, Heart Attack, High Blood Pressure, Hypertension, Heart Failure, Congestive Heart Failure

Qbrelis patient information at Drugs.com